Induced Pluripotent Stem Cells in Cardiovascular Medicine
Induced pluripotent stem (iPS) cells are generated by reprogramming human somatic cells through the forced expression of several embryonic stem (ES) cell-specific transcription factors. The potential of iPS cells is having a significant impact on regenerative medicine, with the promise of infinite s...
Saved in:
Main Authors: | Toru Egashira, Shinsuke Yuasa, Keiichi Fukuda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.4061/2011/348960 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of artificial intelligence in induced pluripotent stem cell-based technology over 10-year period: A systematic scoping review.
by: Quan Duy Vo, et al.
Published: (2024-01-01) -
Advances in Induced Pluripotent Stem Cell Technologies
by: Rajarshi Pal, et al.
Published: (2012-01-01) -
Induced Pluripotent Stem Cells and Outer Retinal Disease
by: Jin Yang, et al.
Published: (2016-01-01) -
Reprogramming of Mouse Calvarial Osteoblasts into Induced Pluripotent Stem Cells
by: Yinxiang Wang, et al.
Published: (2018-01-01) -
Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
by: Methichit Wattanapanitch
Published: (2019-01-01)